抗癌药Vitrakvi(larotrectinib)上市 对17种癌症有效( 六 )

美国Larotrectinib相关临床试验信息可点击以下链接了解:

https://clinicaltrials.gov/ct2/results?cond=&term=LOXO+TRK&cntry=&state=&city=&dist

参考来源:

https://ir.loxooncology.com/press-releases/2372560-Loxo-oncology-announces-larotrectinib-clinical-update-in-patients-with-trk-fusion-cancers-at-the-european-society-for-medical-oncology-2018-congress

https://www.nejm.org/doi/full/10.1056/NEJMoa1714448

原文标题:可治疗17种癌症的抗癌药Vitrakvi(larotrectinib)获批上市

原文链接:https://www.haoeyou.com/zhongliu_aizheng/qita/20181128/1741.html